These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26432234)

  • 21. The structure the sales force supports.
    Stephenson R
    MPS; 1978 Oct; 9(10):24, 27, 36. PubMed ID: 10238855
    [No Abstract]   [Full Text] [Related]  

  • 22. Petition calls for clampdown on absentee Chinese researchers.
    Cyranoski D
    Nature; 2003 Jan; 421(6918):3. PubMed ID: 12511918
    [No Abstract]   [Full Text] [Related]  

  • 23. [Some approaches to the calculation of the intralaboratory costs of analyses in an automated laboratory].
    Bol'shakova TD; Aleksandrovskaia TN; Sitnikova LA; Solov'ev LS; Lukicheva TI; Fel'shina EI
    Lab Delo; 1990; (2):58-61. PubMed ID: 1692373
    [No Abstract]   [Full Text] [Related]  

  • 24. Seven ways scientists handle technology challenges in resource-poor settings.
    Choi CQ
    Nature; 2019 May; 569(7754):147-148. PubMed ID: 31043720
    [No Abstract]   [Full Text] [Related]  

  • 25. Denmark in focus.
    Med Device Technol; 2004; 15(1):74. PubMed ID: 14994640
    [No Abstract]   [Full Text] [Related]  

  • 26. Drugs, devices and doctors.
    Krugman P
    N Y Times Web; 2005 Dec; ():A41. PubMed ID: 16450464
    [No Abstract]   [Full Text] [Related]  

  • 27. [Implants and hospital pricing].
    Papin P
    Rev Chir Orthop Reparatrice Appar Mot; 2008 Oct; 94 Suppl(6):S91-5. PubMed ID: 18928794
    [No Abstract]   [Full Text] [Related]  

  • 28. Pricing problem.
    Frisch S
    Minn Med; 2013 Apr; 96(4):18-23. PubMed ID: 23926823
    [No Abstract]   [Full Text] [Related]  

  • 29. Practice expenses creep back up.
    Goldberg JH
    Med Econ; 1996 Nov; 73(22):134-6, 138-42, 144. PubMed ID: 10162649
    [No Abstract]   [Full Text] [Related]  

  • 30. Open-access publishing can survive recession.
    Aerts R
    Nature; 2009 Apr; 458(7241):967. PubMed ID: 19396122
    [No Abstract]   [Full Text] [Related]  

  • 31. Supply costs dominate high-cost DRGs.
    Healthc Financ Manage; 2005 Jan; 59(1):100. PubMed ID: 15689019
    [No Abstract]   [Full Text] [Related]  

  • 32. Counting the chemicals.
    Marris E
    Nature; 2007 May; 447(7144):516-7. PubMed ID: 17563934
    [No Abstract]   [Full Text] [Related]  

  • 33. Life in the stone age. By Caveman.
    J Cell Sci; 2001 Jun; 114(Pt 12):2205-6. PubMed ID: 11493656
    [No Abstract]   [Full Text] [Related]  

  • 34. Counting the cost.
    Powell K
    Nature; 2005 Apr; 434(7036):1048-9. PubMed ID: 15846352
    [No Abstract]   [Full Text] [Related]  

  • 35. The device industry in Germany.
    Schmitt JM
    Med Device Technol; 1997 Nov; 8(9):36. PubMed ID: 10174628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Financing of equipment in ophthalmology].
    Seegmuller JL
    Annee Ther Clin Ophtalmol; 1986; 37():271-82. PubMed ID: 3674822
    [No Abstract]   [Full Text] [Related]  

  • 37. China: In their words.
    Nature; 2008 Jul; 454(7203):399-402. PubMed ID: 18650893
    [No Abstract]   [Full Text] [Related]  

  • 38. Partnering with your suppliers. A lesson from industry.
    Ziehr J
    J Healthc Mater Manage; 1992 Aug; 10(7):42-6. PubMed ID: 10119550
    [No Abstract]   [Full Text] [Related]  

  • 39. Michigan lab axed as Pfizer cuts costs.
    Wadman M
    Nature; 2007 Feb; 445(7127):466-7. PubMed ID: 17268437
    [No Abstract]   [Full Text] [Related]  

  • 40. A dynamic industry where innovation is a priority.
    Med Device Technol; 2005 Oct; 16(8):38-42. PubMed ID: 16355971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.